In addition, studies conducted by Castellano et al. [24] and Kuriyama et al. [25] identified that a low pre-treatment serum ALB level is a factor that is independently associated with worse OS in HCC patients treated with percutaneous ethanol injection (PEI). The gene discussed is ALB; the disease is hepatocellular carcinoma.